user

Social Disparities Predict Successful Implementation of Neoadjuvant Chemotherapy in Resectable Pancreatic Adenocarcinoma

被引：0
|
作者：
Fromer, M. W. [1 ]
Mouw, T. J. [1 ]
Egger, M. E. [1 ]
Scoggins, C. R. [1 ]
Philips, P. [1 ]
McMasters, K. M. [1 ]
Martin, R. C. [1 ]
机构：
[1] Univ Louisville, Surg, Louisville, KY 40292 USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2021年 / 28卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P127
引用
收藏
页码：S92 / S92
页数：1
相关论文
共 50 条
  • [1] A Qualitative Review of Neoadjuvant Chemotherapy in Resectable Pancreatic Adenocarcinoma
    Blair, Alex B.
    Sorber, Rebecca
    Rozich, Noah S.
    Burkhart, Richard A.
    [J]. PANCREAS, 2019, 48 (08) : 973 - 984
  • [2] Neoadjuvant chemotherapy improves outcomes in resectable pancreatic adenocarcinoma
    Christopher, Wade
    Nassoiy, Sean
    Marcus, Rebecca
    Keller, Jennifer
    Chang, Shu-Ching
    Fischer, Trevan
    Bilchik, Anton
    Goldfarb, Melanie
    [J]. SURGERY IN PRACTICE AND SCIENCE, 2022, 11
  • [3] The Fate of Resectable Pancreatic Adenocarcinoma After Neoadjuvant Chemotherapy
    Irfan, Ahmer
    Rose, J. Bart
    Wang, Thomas N.
    Vickers, Selwyn M.
    Dudeja, Vikas
    Gbolahan, Olumide
    Reddy, Sushanth
    [J]. PANCREAS, 2022, 51 (01) : 100 - 105
  • [4] Disparities in the Use of Neoadjuvant Therapy for Resectable Pancreatic Ductal Adenocarcinoma
    Cloyd, Jordan M.
    Shen, Chengli
    Santry, Heena
    Bridges, John
    Dillhoff, Mary
    Ejaz, Aslam
    Pawlik, Timothy M.
    Tsung, Allan
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020, 18 (05): : 556 - +
  • [5] Efficacy of Neoadjuvant Chemotherapy and Radiation in Resectable/Borderline Resectable Pancreatic Ductal Adenocarcinoma
    Kelley, Jesse K.
    Kolbeinsson, Hordur
    Eastburg, Benjamin
    Frisch, Austin
    Khan, Mariam
    Wright, Gerald P.
    Assifi, Mura
    Chandra, Sreenivasa
    Chung, Mathew
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (SUPPL 1) : S176 - S177
  • [6] Disparities in neoadjuvant chemotherapy for pancreatic adenocarcinoma with vascular involvement
    Chervu, Nikhil
    Kim, Shineui
    Sakowitz, Sara
    Le, Nguyen
    Mallick, Saad
    Lee, Hanjoo
    Benharash, Peyman
    Donahue, Timothy
    [J]. SURGERY OPEN SCIENCE, 2024, 20 : 101 - 105
  • [7] Current view of neoadjuvant chemotherapy in primarily resectable pancreatic adenocarcinoma
    Eid, Michal
    Ostrizkova, Lenka
    Kunovsky, Lumir
    Brancikova, Dagmar
    Kala, Zdenek
    Hlavsa, Jan
    Janecek, Pavel
    Kosikova, Ivana
    Blazkova, Monika
    Slaby, Ondrej
    Mayer, Jiri
    [J]. NEOPLASMA, 2021, 68 (01) : 1 - 9
  • [8] Neoadjuvant chemotherapy is superior to adjuvant treatment in resectable pancreatic adenocarcinoma
    Artinyan, A.
    Anaya, D.
    Mailey, B.
    Ellenhorn, J. D.
    Kim, J.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2010, 17 : S80 - S81
  • [9] Neoadjuvant Chemotherapy Versus Upfront Surgery for Resectable Pancreatic Adenocarcinoma
    Sugawara, Toshitaka
    Rodriguez Franco, Salvador
    Sherman, Samantha
    Torphy, Robert
    Colborn, Kathryn
    Franklin, Oskar
    Ishida, Jun
    Grandi, Samuele
    Al-Musawi, Mohammed
    Gleisner, Ana
    Schulick, Richard
    Del Chiaro, Marco
    [J]. ANNALS OF SURGERY, 2024, 279 (02) : 331 - 339
  • [10] Outcomes of Neoadjuvant Chemoradiation With and Without Systemic Chemotherapy in Resectable and Borderline Resectable Pancreatic Adenocarcinoma
    Trinh, Katherine, V
    Fischer, Dawn A.
    Gardner, Timothy B.
    Smith, Kerrington D.
    [J]. FRONTIERS IN ONCOLOGY, 2020, 10
12345